Skip to main content

Table 1 Main clinical process of the first case co-infected by avian influenza A H7N9 and mycoplasma pneumoniae in Kaili, Guizhou province, China

From: Clinical characteristics from co-infection with avian influenza A H7N9 and Mycoplasma pneumoniae: a case report

Course Date Clinical major events
day 1 5 January, 2017 Fever, cough, abdominal distention, weakness, anorexia
day 7 11 January, 2017 Went to see doctor, and sputum and throat swabs were collected to be checked for the presence of avian influenza virus
day 9 13 January, 2017 Admitted to Second Affiliated Hospital of Guizhou Medical University, CT scan showed obvious consolidation and infiltration in bilateral lungs and ground-glass changes in upper area of right lung; and she was diagnosed with pneumoniae, Oseltamivir and meropenem were administered
day 10 14 January, 2017 Result of neucleic acid testing for H7N9 was positive and the patient was transferred to ICU because of illness deterioration and ARDS. Non-invasive MV. Titer of antibody to mycoplasma pneumoniae was 1:80;
day 14 18 January, 2017 CHest X-ray showed the infectious focus of bilateral lung partially absorbed.
day 15 19 January, 2017 Cough again with fewer sputum, other symptoms exacerbated again, increase of moist rale in upper area in right lung; Titer of antibody to mycoplasma pneumoniae rised to 1:160;
day 19 23 January, 2017 CT scan showed new focus appearing in upper aera while old infultration being absorbed. Titer of antibody to mycoplasma pneumoniae arrived to 1:640, and azithromycin and moxifloxacin were administered.
day 19 23 January, 2017 Oseltamivir was discontinued because of three continual examinations of neucleic acid for influenza A H7N9 changed to negative
day 22 26 January, 2017 CT scan shground-glass focus enlarged comparing to that at 12 days before.
day 25 29 January, 2017 The titer of the antibody decreased to 1:320.Patient’s symptoms were alleviated and moist rales reduced
day 32 4 February, 2017 CT scan revealed the right upper focus obviously absorbed. Moxifloxacin was discontinued while azithromycin was till continued.
day 33 5 February, 2017 Discharged from hospital.
day 35 7 February, 2017 Titier of antibody to M. pneumoniae decreased to 1:80.
day 41 13 February, 2017 All symptoms disappeared and azithromycin discontinued.